How to determine if you’re at risk for adult ADHD
UC expert featured in National Geographic article
The University of Cincinnati's Stephen Rush was featured in a National Geographic article discussing current research into the causes and characteristics of ADHD, particularly when it is diagnosed in adults.
"The predominant theory is primarily genetics and the biology of what’s going on in the brain that seems to be associated with it," said Rush, MD, associate professor of clinical psychiatry in UC's College of Medicine, medical director of ambulatory services and a UC Health physician. Studies show that about 80 percent of the time there is a similar genetic component found among people who have ADHD compared to people who do not have it.
Our brains have “a polygenic architecture,” Rush continued. “And what that means is that there are hundreds of potential genes contributing to small effects. Their interaction, and the interaction that those genes have, even with the environment, shapes the risk for a diagnosis of ADHD.”
Read the National Geographic article.
Featured photo at top of wooden blocks spelling ADHD. Photo/anilakkus/iStock Photo.
Related Stories
Why so much hype around the new Grand Theft Auto?
November 6, 2026
UC experts from DAAP's game and animation program to a doctor at the Lindner Center of HOPE discuss the pros and cons surrounding the upcoming billion-dollar game Grand Theft Auto VI.
Are you experiencing “post-election stress disorder”?
November 6, 2026
Feelings of stress and anxiety tied to election results can persist even after the votes are counted, said University of Cincinnati psychiatrist Julia Stimpfl, MD, even though “post-election stress disorder” is not officially recognized as a mental illness. As she recently told Spectrum News 1 Ohio, those feelings can linger even after an election is finalized.
New UC research identifies biological differences in pancreatic cancer
November 6, 2026
University of Cincinnati Cancer Center research published in Cancer Research found differences in pancreatic cancer tumors and immune environments, opening the possibility for more personalized treatments.